79 related articles for article (PubMed ID: 27304847)
1. Systematic review of outcomes after distal pancreatectomy with coeliac axis resection for locally advanced pancreatic cancer.
Klompmaker S; de Rooij T; Korteweg JJ; van Dieren S; van Lienden KP; van Gulik TM; Busch OR; Besselink MG
Br J Surg; 2016 Jul; 103(8):941-9. PubMed ID: 27304847
[TBL] [Abstract][Full Text] [Related]
2. Perioperative and long-term survival outcomes of pancreatectomy with arterial resection in borderline resectable or locally advanced pancreatic cancer following neoadjuvant therapy: a systematic review and meta-analysis.
Xue K; Huang X; Zhao P; Zhang Y; Tian B
Int J Surg; 2023 Dec; 109(12):4309-4321. PubMed ID: 38259002
[TBL] [Abstract][Full Text] [Related]
3. Effect of adjuvant chemotherapy after pancreatectomy in patients with node-negative pancreatic cancer: target trial emulation.
Kirkegård J; Ladekarl M; Johannsen IR; Mortensen F
Br J Surg; 2024 Jan; 111(1):. PubMed ID: 38006324
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic neuroendocrine tumors: Preoperative factors that predict lymph node metastases to guide operative strategy.
Postlewait LM; Ethun CG; Baptiste GG; Le N; McInnis MR; Cardona K; Russell MC; Sarmiento JM; Kooby DA; Staley CA; Maithel SK
J Surg Oncol; 2016 Sep; 114(4):440-5. PubMed ID: 27334541
[TBL] [Abstract][Full Text] [Related]
5. Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study.
Klompmaker S; van Hilst J; Gerritsen SL; Adham M; Teresa Albiol Quer M; Bassi C; Berrevoet F; Boggi U; Busch OR; Cesaretti M; Dalla Valle R; Darnis B; De Pastena M; Del Chiaro M; Grützmann R; Diener MK; Dumitrascu T; Friess H; Ivanecz A; Karayiannakis A; Fusai GK; Labori KJ; Lombardo C; López-Ben S; Mabrut JY; Niesen W; Pardo F; Perinel J; Popescu I; Roeyen G; Sauvanet A; Prasad R; Sturesson C; Lesurtel M; Kleeff J; Salvia R; Besselink MG;
Ann Surg Oncol; 2018 May; 25(5):1440-1447. PubMed ID: 29532342
[TBL] [Abstract][Full Text] [Related]
6. Surgical Indications of Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Body/Tail Cancer.
Sugiura T; Okamura Y; Ito T; Yamamoto Y; Uesaka K
World J Surg; 2017 Jan; 41(1):258-266. PubMed ID: 27473130
[TBL] [Abstract][Full Text] [Related]
7. Distal Pancreatectomy with en Bloc Celiac Axis Resection (Modified Appleby Procedure) for Locally Advanced Pancreatic Body Cancer: A Single-Center Review of 80 Consecutive Patients.
Nakamura T; Hirano S; Noji T; Asano T; Okamura K; Tsuchikawa T; Murakami S; Kurashima Y; Ebihara Y; Nakanishi Y; Tanaka K; Shichinohe T
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):969-975. PubMed ID: 27495282
[TBL] [Abstract][Full Text] [Related]
8. Vascular Resection for Pancreatic Cancer: 2019 French Recommendations Based on a Literature Review From 2008 to 6-2019.
Delpero JR; Sauvanet A
Front Oncol; 2020; 10():40. PubMed ID: 32117714
[No Abstract] [Full Text] [Related]
9. Pancreatoduodenectomy With Arterial Resection for Locally Advanced Pancreatic Cancer of the Head: A Systematic Review.
Haines M; Chua TC; Jamieson NB; Mittal A; Gill AJ; Samra JS
Pancreas; 2020; 49(5):621-628. PubMed ID: 32433398
[TBL] [Abstract][Full Text] [Related]
10. Radical pancreatic cancer surgery-with arterial resection.
Klaiber U; Mihaljevic A; Hackert T
Transl Gastroenterol Hepatol; 2019; 4():8. PubMed ID: 30976711
[TBL] [Abstract][Full Text] [Related]
11. Pancreatectomy with arterial resection is superior to palliation in patients with borderline resectable or locally advanced pancreatic cancer.
Del Chiaro M; Rangelova E; Halimi A; Ateeb Z; Scandavini C; Valente R; Segersvärd R; Arnelo U; Verbeke CS
HPB (Oxford); 2019 Feb; 21(2):219-225. PubMed ID: 30093144
[TBL] [Abstract][Full Text] [Related]
12. Combined hepatic arterial resection in pancreatic resections for locally advanced pancreatic cancer.
Miyazaki M; Yoshitomi H; Takano S; Shimizu H; Kato A; Yoshidome H; Furukawa K; Takayashiki T; Kuboki S; Suzuki D; Sakai N; Ohtuka M
Langenbecks Arch Surg; 2017 May; 402(3):447-456. PubMed ID: 28361216
[TBL] [Abstract][Full Text] [Related]
13. Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature.
Lovecek M; Skalicky P; Chudacek J; Szkorupa M; Svebisova H; Lemstrova R; Ehrmann J; Melichar B; Yogeswara T; Klos D; Vrba R; Havlik R; Mohelnikova-Duchonova B
World J Gastroenterol; 2017 Sep; 23(35):6420-6428. PubMed ID: 29085191
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of IGF2BP2 by multiple mechanisms in pancreatic cancer promotes cancer proliferation by activating the PI3K/Akt signaling pathway.
Xu X; Yu Y; Zong K; Lv P; Gu Y
J Exp Clin Cancer Res; 2019 Dec; 38(1):497. PubMed ID: 31852504
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Autophagy by Deguelin Sensitizes Pancreatic Cancer Cells to Doxorubicin.
Xu XD; Zhao Y; Zhang M; He RZ; Shi XH; Guo XJ; Shi CJ; Peng F; Wang M; Shen M; Wang X; Li X; Qin RY
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208617
[TBL] [Abstract][Full Text] [Related]
16. A new approach: Evaluation of necroptosis and immune status enables prediction of the tumor microenvironment and treatment targets in pancreatic cancer.
Lu SY; Hua J; Liu J; Wei MY; Liang C; Meng QC; Zhang B; Yu XJ; Wang W; Xu J; Shi S
Comput Struct Biotechnol J; 2023; 21():2419-2433. PubMed ID: 37090434
[TBL] [Abstract][Full Text] [Related]
17. METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N
Wan W; Ao X; Chen Q; Yu Y; Ao L; Xing W; Guo W; Wu X; Pu C; Hu X; Li Z; Yao M; Luo D; Xu X
Mol Cancer; 2022 Feb; 21(1):60. PubMed ID: 35197058
[TBL] [Abstract][Full Text] [Related]
18. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
19. The Insulin-Like Growth Factor 2 mRNA Binding Protein IMP2/IGF2BP2 is Overexpressed and Correlates with Poor Survival in Pancreatic Cancer.
Dahlem C; Barghash A; Puchas P; Haybaeck J; Kessler SM
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261900
[TBL] [Abstract][Full Text] [Related]
20. METTL3 facilitates tumor progression via an m
Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH
Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
